GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
61.51
+0.75 (1.23%)
At close: May 18, 2026, 4:00 PM EDT
61.70
+0.19 (0.31%)
After-hours: May 18, 2026, 7:59 PM EDT
GEHC Revenue
GE HealthCare Technologies had revenue of $5.13B in the quarter ending March 31, 2026, with 7.41% growth. This brings the company's revenue in the last twelve months to $20.98B, up 5.97% year-over-year. In the year 2025, GE HealthCare Technologies had annual revenue of $20.63B with 4.84% growth.
Revenue (ttm)
$20.98B
Revenue Growth
+5.97%
P/S Ratio
1.33
Revenue / Employee
$388,500
Employees
54,000
Market Cap
27.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.63B | 953.00M | 4.84% |
| Dec 31, 2024 | 19.67B | 120.00M | 0.61% |
| Dec 31, 2023 | 19.55B | 1.21B | 6.60% |
| Dec 31, 2022 | 18.34B | 756.00M | 4.30% |
| Dec 31, 2021 | 17.59B | 421.00M | 2.45% |
| Dec 31, 2020 | 17.16B | 531.00M | 3.19% |
| Dec 31, 2019 | 16.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boston Scientific | 20.61B |
| Koninklijke Philips | 20.34B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
| STERIS | 5.94B |
| DexCom | 4.82B |
| Globus Medical | 3.10B |
GEHC News
- 6 days ago - GE HealthCare Technologies Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 days ago - GE HealthCare to highlight AI-enabled solutions at ESTRO 2026 Congress - TheFly
- 6 days ago - ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions - Business Wire
- 7 days ago - GE HealthCare highlights next-generation SIGNA MR systems - TheFly
- 7 days ago - GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact - Business Wire
- 11 days ago - GE HealthCare Technologies Transcript: AGM 2026 - Transcripts
- 18 days ago - GE HealthCare Technologies Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 18 days ago - GE HealthCare price target lowered to $85 from $89 at Oppenheimer - TheFly